| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 29, 2026 | ±2.3% | +1.2% | over-priced |
| July 30, 2025 | ±1.7% | -1.7% | under-priced |
| April 30, 2025 | ±2.7% | +1.1% | over-priced |
| October 30, 2024 | ±2.4% | +0.5% | over-priced |
| August 7, 2024 | ±3.6% | -0.6% | over-priced |
| May 8, 2024 | ±3.0% | -2.7% | over-priced |
| October 27, 2023 | ±3.1% | -1.3% | over-priced |
| August 4, 2023 | ±3.2% | -0.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $4.20 | $2.4B | $415M |
| Q4 FY2025 | — | $0 | $0 |
| Q3 FY2025 | — | $0 | $0 |
| Q2 FY2025 | $3.75 | $2.3B | $367M |
Equinix, Inc. Common Stock REIT (EQIX) reports in 112 days, with the next report estimated for October 3, 2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced EQIX's earnings risk. Fundamentals into the print: EPS up 20.0% year-over-year, revenue up 9.8%. QuantLogix's live 5-factor engine currently reads EQIX as a buy at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →